Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
C C- C1 C3 C5 C6 C7 CA CB CC CD CE CF CG CH CI CJ CK CL CM CN CO CP CQ CR CS CT CU CV CW CX CY CZ
CI CI CI- CI1 CI3 CI9 CIA CIB CIC CIF CIG CII CIL CIM CIN CIP CIR CIS CIT CIV
selected terms: 72
 
 page 1 of 1

1. 13 cis retinoate
[a topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. ( CSP )] (UMLS (CSP) C0022265) =Organic Chemical; Pharmacologic Substance =Retinoic Acid Agent;
retinoate;
[DE751] ANTIACNE AGENTS, SYSTEMIC;
=ISOTRETINOIN 10 MG;
ISOTRETINOIN 40 MG;
ISOTRETINOIN 20 MG;
37. Cisplatin/Etoposide/Monoclonal Antibody 11D10 Anti-Idiotype Vaccine/Monoclonal Antibody GD2 Anti-Idiotype Vaccine
(UMLS (NCI) C1327759) =Therapeutic or Preventive Procedure; ;
2. 9-cis-Retinoic Acid/Interferon Alfa
[A combination drug therapy. ( NCI )] (UMLS (NCI) C0338247) =Therapeutic or Preventive Procedure
38. Cisplatin/Etoposide/Tirapazamine
(UMLS (NCI) C0935711) =Therapeutic or Preventive Procedure
3. 9-cis-Retinoic Acid/Tamoxifen
(UMLS (NCI) C0338279) =Therapeutic or Preventive Procedure ;
39. Cisplatin/Etoposide/Topotecan
(UMLS (NCI) C1327935) =Therapeutic or Preventive Procedure; ;
4. CIS
[Cytokine Inducible SH2-Containing Protein, encoded by the human CISH gene, is a cytokine-inducible negative regulator of cytokine signaling. This protein contains a SH2 domain and a SOCS box domain. The expression of this gene can be induced by IL2, IL3, GM-CSF and EPO in hematopoietic cells. Proteasome-mediated degradation of this protein is involved in the inactivation of the erythropoietin receptor. Association with EPOR may target this protein for proteolysis by the ubiquitin-dependent proteasome pathway. The CISH protein is mainly monoubiquitinated (37 kD) but may also exist in a polyubiquitinated form (45 kD). Three isoforms (1, 1B, 1C) are produced by alternative splicing, and the tissue distribution of isoforms 1 and 1B is distinct. (From LocusLink, Swiss-Prot and NCI) ( NCI )] (UMLS (NCI) C0299250) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
40. Cisplatin/Fenretinide/Paclitaxel
(UMLS (NCI) C0879503) =Therapeutic or Preventive Procedure ;
5. cis acting element
[ ] (UMLS (CSP) C0599780) =Nucleotide Sequence ;
41. Cisplatin/Filgrastim/Fluorouracil/Paclitaxel
(UMLS (NCI) C1327998) =Therapeutic or Preventive Procedure ;
6. CIS Family Gene
[Suppressor of Cytokine Signaling (SOCS/SSI) Family Genes encode cytokine-specific-inducible negative feedback regulators that function downstream of cytokine receptors to attenuate signal transduction. Suppressor of Cytokine Signaling Proteins contain SH2 and SOCS BOX domains and are implicated, through SOCS box binding, in ubiquitin-dependent protein degradation. SOCS proteins interact with multiple tyrosine kinase activated signaling proteins and inhibit cytokine signal transduction by binding to tyrosine kinase receptors. SOCS proteins regulate cell growth and survival, placental development, hematopoiesis, and T-cell allergic responses. (NCI) ( NCI )] (UMLS (NCI) C1336533) Cytokine-Induced STAT Inhibitor Family Gene;
SOCS Family Gene;
SSI Family Gene;
STAT-Induced STAT Inhibitor Family Gene;
Suppressor of Cytokine Signaling Family Gene =Gene or Genome ;
42. Cisplatin/Flavopiridol/Irinotecan
(UMLS (NCI) C1327785) =Therapeutic or Preventive Procedure ;
7. CIS Family Protein
[Encoded by Suppressor of Cytokine Signaling (SOCS/SSI) Family Genes, Suppressor of Cytokine Signaling Family Proteins are cytokine-specific-inducible negative feedback regulators that function downstream of cytokine receptors to attenuate signal transduction. Containing SH2 and SOCS BOX domains, SOCS proteins are implicated, through SOCS box binding, in ubiquitin-dependent protein degradation. SOCS proteins interact with multiple tyrosine kinase activated signaling proteins and inhibit cytokine signal transduction by binding to tyrosine kinase receptors. SOCS proteins regulate cell growth and survival, placental development, hematopoiesis, and T-cell allergic responses. (NCI) ( NCI )] (UMLS (NCI) C1336534) Cytokine-Induced STAT Inhibitor Family Protein;
SOCS Family Protein;
SSI Family Protein;
STAT-Induced STAT Inhibitor Family Protein;
Suppressor of Cytokine Signaling Family Protein =Amino Acid, Peptide, or Protein ;
43. Cisplatin/Flavopiridol/Paclitaxel
(UMLS (NCI) C0796644) =Therapeutic or Preventive Procedure
8. cis trans isomerization
[isomerism that occurs in compounds with double bonds; since the double bond is rigid, atoms and functional groups are not free to rotate; the cis isomer has the two groups on the same side of the double bond, the trans isomer on opposite sides. ( CSP )] (UMLS (CSP) C0596342) =Molecular Function; Spatial Concept =stereochemistry;
44. Cisplatin/Fluorouracil/G17DT
(UMLS (NCI) C0935890) =Therapeutic or Preventive Procedure
9. Cis-1,1-diamino-methylcyclohexane sulfato-platinum
[A synthetic derivative of cyclohexane sulfatoplatinum with antineoplastic properties. Spiroplatin induces DNA cross-links, thereby inhibiting DNA replication and RNA and protein synthesis. Similar to other platinum compounds, this agent has been shown to be mutagenic and carcinogenic. (NCI04) ( NCI )] (UMLS (NCI) C0075022) =Organic Chemical; Pharmacologic Substance ;
45. Cisplatin/Fluorouracil/Gemcitabine
(UMLS (NCI) C0879268) =Therapeutic or Preventive Procedure
10. cis-1,2,3,5-trans-4,6-Cyclohexanehexol
[cyclic sugar alcohol, the fully hydroxylated derivative of cyclohexane, occurring naturally in a variety of stereoisomers, most commonly, the myo-isomer, myoinositol, a member of the vitamin B complex and a component of phosphatidylinositols. ( CSP )] (UMLS (NCI) C0021547) =Carbohydrate; Pharmacologic Substance; Vitamin =sugar alcohol;
[VT100] VITAMIN B;
Inactive Ingredient Preparations;
=inositol phosphate;
Lecithin 420 MG Oral Capsule;
NURSOY LIQUID;
INOSITOL 50 MG;
INOSITOL 0.83 %;
INOSITOL 111 MG;
INOSITOL 111.33 MG;
INOSITOL 19 MG/240ML;
INOSITOL 200 MG/240ML;
INOSITOL 250 MG/L;
INOSITOL 60 MG/240ML
46. Cisplatin/Fluorouracil/Irinotecan
(UMLS (NCI) C0879498) =Therapeutic or Preventive Procedure ;
11. Cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine
[1-acetyl-4-(2,4-dichlorophenyl-2-imidazolylmethyl- 1,3- dioxolanylmethoxyphenyl) piperazine; broad spectrum, oral antifungal. ( CSP )] (UMLS (NCI) C0022625) =Organic Chemical; Pharmacologic Substance =[AM700] ANTIFUNGALS;
imidazole;
Piperazines;
[DE102] ANTIFUNGAL, TOPICAL =KETOCONAZOLE 200 MG;
KETOCONAZOLE 2 %;
KETOCONAZOLE 1 %
47. Cisplatin/Fluorouracil/Irinotecan/Leucovorin Calcium
(UMLS (NCI) C1328117) =Therapeutic or Preventive Procedure; ;
12. cis-4-Amino-5-Chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-Anisamide
[cis-4-amino-5-chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-anisamide; peristaltic stimulant under clinical evaluation for constipation, gastroparesis, intestinal pseudoobstruction, and other GI motility disorders. ( CSP )] (UMLS (NCI) C0072916) =Organic Chemical; Pharmacologic Substance =Benzamides;
[GA000] GASTROINTESTINAL MEDICATIONS;
piperidine;
Piperidines;
phenylamide;
[GA900] GASTRIC MEDICATIONS, OTHER =Cisapride 1 MG/ML;
CISAPRIDE 10 MG;
CISAPRIDE 20 MG
48. Cisplatin/Fluorouracil/Oblimersen
(UMLS (NCI) C1327988) =Therapeutic or Preventive Procedure ;
13. CISH
[This gene plays a role in cellular signaling. ( NCI )] (UMLS (NCI) C1332762) CISH Gene;
Cytokine-Inducible SH2-Containing Protein Gene =Gene or Genome
49. Cisplatin/Fluorouracil/Paclitaxel/Pegfilgrastim
(UMLS (NCI) C1327999) =Therapeutic or Preventive Procedure ;
14. Cisplatin Liposomal
[A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of cisplatin covered by a single lipid bilayer. Encasement in liposomes improves cisplatin's tumor bioavailability and toxicity profile. Liposomal encapsulation does not affect the pharmacological properties of cisplatin directly. Cisplatin forms highly reactive, charged, platinum complexes which bind to nucleophilic groups such as GC-rich sites in DNA, inducing intrastrand and interstrand DNA cross-links, as well as DNA-protein cross-links. These cross-links result in apoptosis and cell growth inhibition. (NCI04) ( NCI )] (UMLS (NCI) C0796445) Cisplatin, Liposomal;
Liposomal Cisplatin;
=Pharmacologic Substance; Inorganic Chemical
50. Cisplatin/Fluoxetine/Gemcitabine
(UMLS (NCI) C1134649) =Therapeutic or Preventive Procedure
15. Cisplatin/Cyclophosphamide/Dexamethasone/Etoposide/Thalidomide
[A chemotherapy combination used in the treatment of cancers such as multiple myeloma and consisting of dexamethasone (antiinflammatory), cisplatin, Dexamethasone, cyclophosphamide, etoposide (cytostatic) and thalidomide (antiangiogenic). (NCI04) ( NCI )] (UMLS (NCI) C0879504) =Therapeutic or Preventive Procedure ;
51. Cisplatin/Gefitinib
(UMLS (NCI) C1134608) =Therapeutic or Preventive Procedure
16. Cisplatin/Cyclophosphamide/Etoposide/Mafosfamide/Vincristine
(UMLS (NCI) C0879463) =Therapeutic or Preventive Procedure ;
52. Cisplatin/Gefitinib/Gemcitabine
(UMLS (NCI) C0879545) =Therapeutic or Preventive Procedure ;
17. Cisplatin/Cyclophosphamide/Etoposide/Methotrexate/Vincristine
(UMLS (NCI) C0935684) =Therapeutic or Preventive Procedure
53. Cisplatin/Gemcitabine/ISIS 3521
(UMLS (NCI) C1327905) =Therapeutic or Preventive Procedure ;
18. Cisplatin/Cytarabine/Dexamethasone/Rituximab
(UMLS (NCI) C0879479) =Therapeutic or Preventive Procedure ;
54. Cisplatin/Gemcitabine/LY293111
(UMLS (NCI) C1328131) =Therapeutic or Preventive Procedure ;
19. Cisplatin/Cytarabine/Etoposide/Ifosfamide/Yttrium Y 90 Humanized Epratuzumab
(UMLS (NCI) C0879366) =Therapeutic or Preventive Procedure ;
55. Cisplatin/Gemcitabine/Paclitaxel
(UMLS (NCI) C0879597) =Therapeutic or Preventive Procedure
20. Cisplatin/Cytarabine/Methylprednisolone/Pixantrone
(UMLS (NCI) C1327856) =Therapeutic or Preventive Procedure
56. Cisplatin/Gemcitabine/Prinomastat
(UMLS (NCI) C0879381) =Therapeutic or Preventive Procedure
21. Cisplatin/Cytarabine/Methylprednisolone/Pixantrone/Rituximab
(UMLS (NCI) C1328021) =Therapeutic or Preventive Procedure; ;
57. Cisplatin/Gemcitabine/Tipifarnib
(UMLS (NCI) C1327900) =Therapeutic or Preventive Procedure ;
22. Cisplatin/Dacarbazine/Doxorubicin/Mitomycin/Sargramostim
(UMLS (NCI) C1134619) =Therapeutic or Preventive Procedure ;
58. Cisplatin/Gemcitabine/Trastuzumab
(UMLS (NCI) C0935853) =Therapeutic or Preventive Procedure
23. Cisplatin/Dexamethasone/Gemcitabine
(UMLS (NCI) C0935814) =Therapeutic or Preventive Procedure
59. Cisplatin/Imatinib Mesylate/Irinotecan
(UMLS (NCI) C1327758) =Therapeutic or Preventive Procedure; ;
24. Cisplatin/Dexrazoxane/Doxorubicin
(UMLS (NCI) C0796699) =Therapeutic or Preventive Procedure ;
60. Cisplatin/Irinotecan/SU5416
(UMLS (NCI) C0879553) =Therapeutic or Preventive Procedure
25. Cisplatin/Dimesna/Docetaxel
(UMLS (NCI) C1328145) =Therapeutic or Preventive Procedure ;
61. Cisplatin/Ixabepilone
(UMLS (NCI) C1327923) =Therapeutic or Preventive Procedure ;
26. Cisplatin/Docetaxel/Trastuzumab
(UMLS (NCI) C0935899) =Therapeutic or Preventive Procedure
62. Cisplatin/Lurtotecan Liposome
(UMLS (NCI) C0879543) =Therapeutic or Preventive Procedure ;
27. Cisplatin/Doxorubicin Hydrochloride Liposome/Mitomycin
(UMLS (NCI) C1327821) =Therapeutic or Preventive Procedure ;
63. Cisplatin/Mitomycin/Tretinoin/Vinorelbine
(UMLS (NCI) C0879501) =Therapeutic or Preventive Procedure ;
28. Cisplatin/Doxorubicin Hydrochloride Liposome/Paclitaxel
(UMLS (NCI) C1327851) =Therapeutic or Preventive Procedure; ;
64. Cisplatin/Raltitrexed
(UMLS (NCI) C0879432) =Therapeutic or Preventive Procedure
29. Cisplatin/Doxorubicin/Etoposide/Ifosfamide/Methotrexate/Trastuzumab
(UMLS (NCI) C1134487) =Therapeutic or Preventive Procedure
65. Cisplatin/Rebeccamycin Analog
(UMLS (NCI) C0879384) Cisplatin/Rebeccamycin Analogue;
=Therapeutic or Preventive Procedure
30. Cisplatin/Doxorubicin/Methotrexate/Trastuzumab
(UMLS (NCI) C1134486) =Therapeutic or Preventive Procedure
66. Cisplatin/S-1
(UMLS (NCI) C1328128) =Therapeutic or Preventive Procedure ;
31. Cisplatin/Edotecarin
(UMLS (NCI) C1328081) =Therapeutic or Preventive Procedure ;
67. Cisplatin/Tirapazamine/Vinorelbine
(UMLS (NCI) C0879461) =Therapeutic or Preventive Procedure ;
32. Cisplatin/Epoetin Alfa
(UMLS (NCI) C0935875) =Therapeutic or Preventive Procedure ;
68. Cisplatin/Tretinoin/Vinorelbine
(UMLS (NCI) C0879502) =Therapeutic or Preventive Procedure ;
33. Cisplatin/Erlotinib
(UMLS (NCI) C1134575) =Therapeutic or Preventive Procedure
69. Cisplatin/UCN-01
(UMLS (NCI) C0935799) =Therapeutic or Preventive Procedure
34. Cisplatin/Erlotinib/Etoposide
(UMLS (NCI) C1327738) =Therapeutic or Preventive Procedure
70. Cisterna of the Rough Endoplasmic Reticulum
(UMLS (NCI) C1180016) =Cell Component ;
35. Cisplatin/Etoposide/Ifosfamide/Prednisolone
(UMLS (NCI) C1134490) =Therapeutic or Preventive Procedure
71. CISTERNAL PUNCTURE
[ ] (UMLS (ICD9CM) C0195877) =Therapeutic or Preventive Procedure
36. Cisplatin/Etoposide/Irinotecan
(UMLS (NCI) C1327936) =Therapeutic or Preventive Procedure; ;
72. cistron
[ ] (UMLS (CSP) C0008844) =Gene or Genome ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM